Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abvc Biopharma (ABVC) Invested Capital (2016 - 2025)

Historic Invested Capital for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to $15.3 million.

  • Abvc Biopharma's Invested Capital rose 50283.98% to $15.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.3 million, marking a year-over-year increase of 50283.98%. This contributed to the annual value of $2.1 million for FY2024, which is 401.03% down from last year.
  • According to the latest figures from Q3 2025, Abvc Biopharma's Invested Capital is $15.3 million, which was up 50283.98% from $10.4 million recorded in Q2 2025.
  • Abvc Biopharma's 5-year Invested Capital high stood at $15.3 million for Q3 2025, and its period low was -$379315.0 during Q2 2023.
  • For the 5-year period, Abvc Biopharma's Invested Capital averaged around $5.8 million, with its median value being $5.1 million (2022).
  • In the last 5 years, Abvc Biopharma's Invested Capital soared by 93304.42% in 2021 and then tumbled by 10387.22% in 2023.
  • Over the past 5 years, Abvc Biopharma's Invested Capital (Quarter) stood at $9.3 million in 2021, then plummeted by 44.62% to $5.1 million in 2022, then tumbled by 58.04% to $2.2 million in 2023, then fell by 4.01% to $2.1 million in 2024, then surged by 640.51% to $15.3 million in 2025.
  • Its Invested Capital was $15.3 million in Q3 2025, compared to $10.4 million in Q2 2025 and $8.8 million in Q1 2025.